🇺🇸 FERRIC AMMONIUM CITRATE in United States

44 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Anaemia — 6 reports (13.64%)
  2. Death — 6 reports (13.64%)
  3. Lower Respiratory Tract Infection — 5 reports (11.36%)
  4. Cytomegalovirus Chorioretinitis — 4 reports (9.09%)
  5. Drug Hypersensitivity — 4 reports (9.09%)
  6. Extrapulmonary Tuberculosis — 4 reports (9.09%)
  7. Hiv Peripheral Neuropathy — 4 reports (9.09%)
  8. Pulmonary Tuberculosis — 4 reports (9.09%)
  9. Virologic Failure — 4 reports (9.09%)
  10. Drug Ineffective — 3 reports (6.82%)

Source database →

FERRIC AMMONIUM CITRATE in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is FERRIC AMMONIUM CITRATE approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for FERRIC AMMONIUM CITRATE in United States?

Marketing authorisation holder not available in our data.